JP2023551519A5 - - Google Patents

Info

Publication number
JP2023551519A5
JP2023551519A5 JP2023532759A JP2023532759A JP2023551519A5 JP 2023551519 A5 JP2023551519 A5 JP 2023551519A5 JP 2023532759 A JP2023532759 A JP 2023532759A JP 2023532759 A JP2023532759 A JP 2023532759A JP 2023551519 A5 JP2023551519 A5 JP 2023551519A5
Authority
JP
Japan
Prior art keywords
pharmaceutical product
product according
days
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023532759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023551519A (ja
Filing date
Publication date
Priority claimed from PCT/US2021/012982 external-priority patent/WO2022115120A1/en
Application filed filed Critical
Priority claimed from PCT/US2021/061145 external-priority patent/WO2022115762A1/en
Publication of JP2023551519A publication Critical patent/JP2023551519A/ja
Publication of JP2023551519A5 publication Critical patent/JP2023551519A5/ja
Pending legal-status Critical Current

Links

JP2023532759A 2020-11-30 2021-11-30 抗cd19抗体とパルサクリシブの組み合わせ療法 Pending JP2023551519A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063119370P 2020-11-30 2020-11-30
US63/119,370 2020-11-30
PCT/US2021/012982 WO2022115120A1 (en) 2020-11-30 2021-01-11 Combination therapy with an anti-cd19 antibody and parsaclisib
USPCT/US2021/012982 2021-01-11
PCT/US2021/061145 WO2022115762A1 (en) 2020-11-30 2021-11-30 Combination therapy with an anti-cd19 antibody and parsaclisib

Publications (2)

Publication Number Publication Date
JP2023551519A JP2023551519A (ja) 2023-12-08
JP2023551519A5 true JP2023551519A5 (cg-RX-API-DMAC7.html) 2024-11-29

Family

ID=79021728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023532759A Pending JP2023551519A (ja) 2020-11-30 2021-11-30 抗cd19抗体とパルサクリシブの組み合わせ療法

Country Status (6)

Country Link
US (2) US20220241411A1 (cg-RX-API-DMAC7.html)
EP (1) EP4251138A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023551519A (cg-RX-API-DMAC7.html)
CA (1) CA3203587A1 (cg-RX-API-DMAC7.html)
TW (1) TW202241436A (cg-RX-API-DMAC7.html)
WO (1) WO2022115762A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016311136B2 (en) 2015-08-21 2022-02-17 Incyte Corporation Combinations and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5156840A (en) 1982-03-09 1992-10-20 Cytogen Corporation Amine-containing porphyrin derivatives
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
EP1294358B1 (en) 2000-06-28 2004-08-18 Smithkline Beecham Plc Wet milling process
US7355008B2 (en) 2003-01-09 2008-04-08 Macrogenics, Inc. Identification and engineering of antibodies with variant Fc regions and methods of using same
AU2004205631A1 (en) 2003-01-16 2004-08-05 Genentech, Inc. Synthetic antibody phage libraries
WO2004072266A2 (en) 2003-02-13 2004-08-26 Kalobios Inc. Antibody affinity engineering by serial epitope-guided complementarity replacement
RS53263B (sr) 2006-08-14 2014-08-29 Xencor Inc. Optimizovana antitela usmerena na cd19
MX389479B (es) 2011-09-02 2025-03-20 Incyte Holdings Corp Heterociclilaminas como inhibidores de fosfoinositida 3-cinasas (pi3k)
TWI736135B (zh) 2013-03-01 2021-08-11 美商英塞特控股公司 吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
SG10201912302VA (en) 2015-02-27 2020-02-27 Incyte Corp Salts of pi3k inhibitor and processes for their preparation
JP6916741B2 (ja) * 2015-05-26 2021-08-11 モルフォシス・アーゲー 抗cd19抗体およびブルトン型チロシンキナーゼ阻害剤の組み合わせ、およびその使用
AU2016311136B2 (en) * 2015-08-21 2022-02-17 Incyte Corporation Combinations and uses thereof
HUE063119T2 (hu) * 2017-05-31 2024-01-28 Morphosys Ag Kezelési paradigma anti-CD19 antitest és venetoclax kombinációs kezeléshez

Similar Documents

Publication Publication Date Title
JP2023551559A5 (cg-RX-API-DMAC7.html)
JP2024069453A5 (cg-RX-API-DMAC7.html)
JP2023524149A5 (cg-RX-API-DMAC7.html)
JP2023542290A5 (cg-RX-API-DMAC7.html)
JP2023542289A5 (cg-RX-API-DMAC7.html)
JP2020503260A5 (cg-RX-API-DMAC7.html)
JP2023541860A5 (cg-RX-API-DMAC7.html)
JP2006522830A5 (cg-RX-API-DMAC7.html)
JP2017514795A5 (cg-RX-API-DMAC7.html)
JP2020525411A5 (cg-RX-API-DMAC7.html)
JP2014533279A5 (cg-RX-API-DMAC7.html)
JP2014114288A5 (cg-RX-API-DMAC7.html)
JP2023541858A5 (cg-RX-API-DMAC7.html)
JP2019517540A5 (cg-RX-API-DMAC7.html)
JP2020524670A5 (cg-RX-API-DMAC7.html)
JP2023542291A5 (cg-RX-API-DMAC7.html)
JP2021501776A5 (cg-RX-API-DMAC7.html)
JP2024543147A5 (cg-RX-API-DMAC7.html)
JP2020523384A5 (cg-RX-API-DMAC7.html)
JP2022512851A5 (cg-RX-API-DMAC7.html)
JP2023520771A5 (cg-RX-API-DMAC7.html)
JP2019532970A5 (cg-RX-API-DMAC7.html)
JP2021523233A5 (cg-RX-API-DMAC7.html)
JP2025512785A5 (cg-RX-API-DMAC7.html)
JP2025500411A5 (cg-RX-API-DMAC7.html)